342 related articles for article (PubMed ID: 35301483)
1. Immunological barriers to haematopoietic stem cell gene therapy.
Charlesworth CT; Hsu I; Wilkinson AC; Nakauchi H
Nat Rev Immunol; 2022 Dec; 22(12):719-733. PubMed ID: 35301483
[TBL] [Abstract][Full Text] [Related]
2. Mobilization-based engraftment of haematopoietic stem cells: a new perspective for chemotherapy-free gene therapy and transplantation.
Canarutto D; Omer Javed A; Pedrazzani G; Ferrari S; Naldini L
Br Med Bull; 2023 Sep; 147(1):108-120. PubMed ID: 37460391
[TBL] [Abstract][Full Text] [Related]
3. Transplantation of gene-modified haematopoietic stem cells: Application and clinical considerations.
Alessandrini M; Krause KH; Speck RF; Pepper MS
S Afr Med J; 2019 Sep; 109(8b):64-69. PubMed ID: 31662152
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo expansion of hematopoietic stem cells: mission accomplished?
Takizawa H; Schanz U; Manz MG
Swiss Med Wkly; 2011; 141():w13316. PubMed ID: 22252776
[TBL] [Abstract][Full Text] [Related]
5. Hematopoietic Stem Cell Gene-Addition/Editing Therapy in Sickle Cell Disease.
Germino-Watnick P; Hinds M; Le A; Chu R; Liu X; Uchida N
Cells; 2022 Jun; 11(11):. PubMed ID: 35681538
[TBL] [Abstract][Full Text] [Related]
6. Parameters affecting successful stem cell collections for genetic therapies in sickle cell disease.
Justus DG; Manis JP
Transfus Apher Sci; 2021 Feb; 60(1):103059. PubMed ID: 33541761
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Different Cytokine Conditions Reveals Resveratrol as a New Molecule for Ex Vivo Cultivation of Cord Blood-Derived Hematopoietic Stem Cells.
Heinz N; Ehrnström B; Schambach A; Schwarzer A; Modlich U; Schiedlmeier B
Stem Cells Transl Med; 2015 Sep; 4(9):1064-72. PubMed ID: 26160960
[TBL] [Abstract][Full Text] [Related]
8. Stem Cell Genetic Therapy for Fanconi Anemia - A New Hope.
Hanenberg H; Roellecke K; Wiek C
Curr Gene Ther; 2017; 16(5):309-320. PubMed ID: 28067166
[TBL] [Abstract][Full Text] [Related]
9. Understanding and overcoming adverse consequences of genome editing on hematopoietic stem and progenitor cells.
Lee BC; Lozano RJ; Dunbar CE
Mol Ther; 2021 Nov; 29(11):3205-3218. PubMed ID: 34509667
[TBL] [Abstract][Full Text] [Related]
10. Angiopoietin-like protein 3 promotes preservation of stemness during ex vivo expansion of murine hematopoietic stem cells.
Farahbakhshian E; Verstegen MM; Visser TP; Kheradmandkia S; Geerts D; Arshad S; Riaz N; Grosveld F; van Til NP; Meijerink JP
PLoS One; 2014; 9(8):e105642. PubMed ID: 25170927
[TBL] [Abstract][Full Text] [Related]
11. Expanding hematopoietic stem cell ex vivo: recent advances and technical considerations.
Rubio-Lara JA; Igarashi KJ; Sood S; Johansson A; Sommerkamp P; Yamashita M; Lin DS
Exp Hematol; 2023; 125-126():6-15. PubMed ID: 37543237
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic stem cell gene editing and expansion: State-of-the-art technologies and recent applications.
Haltalli MLR; Wilkinson AC; Rodriguez-Fraticelli A; Porteus M
Exp Hematol; 2022 Mar; 107():9-13. PubMed ID: 34973360
[TBL] [Abstract][Full Text] [Related]
13. Ex vivo hematopoietic stem cell expansion technologies: recent progress, applications, and open questions.
Meaker GA; Wilkinson AC
Exp Hematol; 2024 Feb; 130():104136. PubMed ID: 38072133
[TBL] [Abstract][Full Text] [Related]
14. Long-term ex vivo haematopoietic-stem-cell expansion allows nonconditioned transplantation.
Wilkinson AC; Ishida R; Kikuchi M; Sudo K; Morita M; Crisostomo RV; Yamamoto R; Loh KM; Nakamura Y; Watanabe M; Nakauchi H; Yamazaki S
Nature; 2019 Jul; 571(7763):117-121. PubMed ID: 31142833
[TBL] [Abstract][Full Text] [Related]
15. CRISPR/Cas9 genome editing in human hematopoietic stem cells.
Bak RO; Dever DP; Porteus MH
Nat Protoc; 2018 Feb; 13(2):358-376. PubMed ID: 29370156
[TBL] [Abstract][Full Text] [Related]
16. LNK (SH2B3) inhibition expands healthy and Fanconi anemia human hematopoietic stem and progenitor cells.
Holdreith N; Lee G; Chandra V; Salinas CS; Nicholas P; Olson TS; Tong W
Blood Adv; 2022 Feb; 6(3):731-745. PubMed ID: 34844262
[TBL] [Abstract][Full Text] [Related]
17. Humanized mice are precious tools for evaluation of hematopoietic gene therapies and preclinical modeling to move towards a clinical trial.
Brendel C; Rio P; Verhoeyen E
Biochem Pharmacol; 2020 Apr; 174():113711. PubMed ID: 31726047
[TBL] [Abstract][Full Text] [Related]
18. Ex vivo expansion of hematopoietic stem cells and gene therapy development.
Zubler RH
Swiss Med Wkly; 2006 Dec; 136(49-50):795-9. PubMed ID: 17299657
[TBL] [Abstract][Full Text] [Related]
19. Physioxia improves the selectivity of hematopoietic stem cell expansion cultures.
Igarashi KJ; Kucinski I; Chan YY; Tan TK; Khoo HM; Kealy D; Bhadury J; Hsu I; Ho PY; Niizuma K; Hickey JW; Nolan GP; Bridge KS; Czechowicz A; Gottgens B; Nakauchi H; Wilkinson AC
Blood Adv; 2023 Jul; 7(14):3366-3377. PubMed ID: 36809781
[TBL] [Abstract][Full Text] [Related]
20. Functional aspects of factor VIII expression after transplantation of genetically-modified hematopoietic stem cells for hemophilia A.
Ide LM; Iwakoshi NN; Gangadharan B; Jobe S; Moot R; McCarty D; Doering CB; Spencer HT
J Gene Med; 2010 Apr; 12(4):333-44. PubMed ID: 20209485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]